These publications were authored or co-authored by Quest Diagnostics staff.
Am J Dermatopathol. 2019 Dec;41(12):953-954.
Disclaimer: One or more of the authors of this publication were employed at the time by Ackerman Academy, a subsidiary of Quest Diagnostics.
Free thyroxine concentrations in sera of individuals with Familial Dysalbuminemic Hyperthyroxinemia: a comparison of three methods of measurement.Authors: Refetoff S, Scherberg N, Yuan C, Wu W, Wu Z, McPhaul MJ.
Thyroid. 2019 Dec 10. doi: 10.1089/thy.2019.0058. [Epub ahead of print]
Immunotherapy- (Blinatumomab-) Related Lineage Switch of KMT2A/AFF1 Rearranged B-Lymphoblastic Leukemia into Acute Myeloid Leukemia/Myeloid Sarcoma and Subsequently into B/Myeloid Mixed Phenotype Acute Leukemia.Authors: He RR, Nayer Z, Hogan M, Cuevo RS, Woodward K, Heyer D, Curtis CA, Peterson JF.
Case Rep Hematol. 2019 Dec 7;2019:7394619.
Pediatr Dermatol. 2019 Dec 7. doi: 10.1111/pde.14070. [Epub ahead of print]
Disclaimer: One or more of the authors of this publication were employed at the time by DermPath, a subsidiary of Quest Diagnostics.
Clin Chem. 2019 Dec;65(12):1487-1492.
Dementia assessment and management in primary care settings: a survey of current provider practices in the United States.Authors: Bernstein A, Rogers KM, Possin KL, Steele NZR, Ritchie CS, Kramer JH, Geschwind M, Higgins JJ, Wohlgemuth J, Pesano R, Miller BL, Rankin KP
BMC Health Serv Res. 2019 Nov 29;19(1):919.
Multilaboratory Comparison of Pneumococcal Multiplex Immunoassays Used in Immunosurveillance of Streptococcus pneumoniae across Europe.Authors: Meek B, Ekström N, Kantsø B, Almond R, Findlow J, Gritzfeld JF, Sværke Jørgensen C, Ljungberg K, Atterfelt F, Batstra MR, Andeweg K, de Jong BAW, Prince HE, Lapé-Nixon M, Gageldonk PGM, Tcherniaeva I, Aaberge I, Herstad TK, Melin M, Rijkers GT, Berbers GA.
mSphere. 2019 Nov 27;4(6).
Specialties: Infectious Disease
Am J Manag Care 2019;25:548-553
Specialties: General Health and Wellness
Blood Cells Mol Dis. 2019 Nov 25;81:102389.
Serum 25-hydroxyvitamin D in the VITamin D and OmegA-3 TriaL (VITAL): Clinical and demographic characteristics associated with baseline and change with randomized vitamin D treatment.Authors: Luttmann-Gibson H, Mora S, Camargo CA, Cook NR, Demler OV, Ghoshal A, Wohlgemuth J, Kulkarni K, Larsen J, Prentice J, Cobble M, Bubes V, Li C, Friedenberg G, Lee IM, Buring JE, Manson JE.
Contemp Clin Trials. 2019 Dec;87:105854.